ArticleAdvances and technical standards in neurosurgery2026
Pineal Tumours: Results, Follow-Up and Sequelae in Children and Adults According to the French Registry of Pineal Tumours and the Lyonnais Registry.
Article in Advances and technical standards in neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPineal tumours remain a challenging pathology, even in the era of molecular classification. The different types of pineal gland tumours require tailored management strategies, determined through a multidisciplinary approach. In this chapter, we present data from the French registry on the management of pineal region tumours in both paediatric and adult populations, with a particular emphasis on differences observed in the Lyon experience. COHORT AND METHOD OF THE DATA ANALYSIS: To ensure uniformity in histological analysis, registry data were reviewed for the period between 1997 and 2022. Consequently, 689 patients from the national registry and 292 from the Lyon series were eligible for inclusion. Clinical and survival analyses were performed, evaluating demographic and clinical data, tumour histology, type of surgery and/or adjuvant treatment, complications and follow-up. Each topic is described in a separate chapter, with data on pineal region tumours analysed and discussed according to histological subtype.
conclusionThe treatment of pineal region tumours remains challenging and their prognosis is still poor. In the future, the advances in genetics and molecular biology could allow more patients to be cured with better tailored treatments. For rare tumours, there is a clear need for structural databases that enable comprehensive evaluation of pineal pathology, encompassing all modern aspects: from clinical presentation to tumour genetics. Continuous input into this registry is therefore essential to enhance our understanding of this group of tumours and to improve the efficacy of management by reducing treatment-related morbidity and the mortality.
Indexed as
Identifiers
42115466What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.